Great Point Partners, LLC 13D and 13G filings for Unicycive Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 3:02 pm Unchanged | 2025-09-30 | 13G | UNICYCIVE THERAPEUTICS INC UNCY | Great Point Partners, LLC | 796,558 4.510% | 0 (Unchanged) | Filing |
| 2025-08-14 5:16 pm Sale | 2025-06-30 | 13G | UNICYCIVE THERAPEUTICS INC UNCY | Great Point Partners, LLC | 796,558 6.240% | -350,759 (-30.57%) | Filing |